Cargando…

Potent inhibition of microRNA in vivo without degradation

Chemically modified antisense oligonucleotides (ASOs) are widely used as a tool to functionalize microRNAs (miRNAs). Reduction of miRNA level after ASO inhibition is commonly reported to show efficacy. Whether this is the most relevant endpoint for measuring miRNA inhibition has not been adequately...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Scott, Propp, Stephanie, Freier, Susan M., Jones, Laura E., Serra, Martin J., Kinberger, Garth, Bhat, Balkrishen, Swayze, Eric E., Bennett, C. Frank, Esau, Christine
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
RNA
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615630/
https://www.ncbi.nlm.nih.gov/pubmed/19015151
http://dx.doi.org/10.1093/nar/gkn904
_version_ 1782163347583533056
author Davis, Scott
Propp, Stephanie
Freier, Susan M.
Jones, Laura E.
Serra, Martin J.
Kinberger, Garth
Bhat, Balkrishen
Swayze, Eric E.
Bennett, C. Frank
Esau, Christine
author_facet Davis, Scott
Propp, Stephanie
Freier, Susan M.
Jones, Laura E.
Serra, Martin J.
Kinberger, Garth
Bhat, Balkrishen
Swayze, Eric E.
Bennett, C. Frank
Esau, Christine
author_sort Davis, Scott
collection PubMed
description Chemically modified antisense oligonucleotides (ASOs) are widely used as a tool to functionalize microRNAs (miRNAs). Reduction of miRNA level after ASO inhibition is commonly reported to show efficacy. Whether this is the most relevant endpoint for measuring miRNA inhibition has not been adequately addressed in the field although it has important implications for evaluating miRNA targeting studies. Using a novel approach to quantitate miRNA levels in the presence of excess ASO, we have discovered that the outcome of miRNA inhibition can vary depending on the chemical modification of the ASO. Although some miRNA inhibitors cause a decrease in mature miRNA levels, we have identified a novel 2′-fluoro/2′-methoxyethyl modified ASO motif with dramatically improved in vivo potency which does not. These studies show there are multiple mechanisms of miRNA inhibition by ASOs and that evaluation of secondary endpoints is crucial for interpreting miRNA inhibition studies.
format Text
id pubmed-2615630
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-26156302009-03-30 Potent inhibition of microRNA in vivo without degradation Davis, Scott Propp, Stephanie Freier, Susan M. Jones, Laura E. Serra, Martin J. Kinberger, Garth Bhat, Balkrishen Swayze, Eric E. Bennett, C. Frank Esau, Christine Nucleic Acids Res RNA Chemically modified antisense oligonucleotides (ASOs) are widely used as a tool to functionalize microRNAs (miRNAs). Reduction of miRNA level after ASO inhibition is commonly reported to show efficacy. Whether this is the most relevant endpoint for measuring miRNA inhibition has not been adequately addressed in the field although it has important implications for evaluating miRNA targeting studies. Using a novel approach to quantitate miRNA levels in the presence of excess ASO, we have discovered that the outcome of miRNA inhibition can vary depending on the chemical modification of the ASO. Although some miRNA inhibitors cause a decrease in mature miRNA levels, we have identified a novel 2′-fluoro/2′-methoxyethyl modified ASO motif with dramatically improved in vivo potency which does not. These studies show there are multiple mechanisms of miRNA inhibition by ASOs and that evaluation of secondary endpoints is crucial for interpreting miRNA inhibition studies. Oxford University Press 2009-01 2008-11-16 /pmc/articles/PMC2615630/ /pubmed/19015151 http://dx.doi.org/10.1093/nar/gkn904 Text en © 2008 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle RNA
Davis, Scott
Propp, Stephanie
Freier, Susan M.
Jones, Laura E.
Serra, Martin J.
Kinberger, Garth
Bhat, Balkrishen
Swayze, Eric E.
Bennett, C. Frank
Esau, Christine
Potent inhibition of microRNA in vivo without degradation
title Potent inhibition of microRNA in vivo without degradation
title_full Potent inhibition of microRNA in vivo without degradation
title_fullStr Potent inhibition of microRNA in vivo without degradation
title_full_unstemmed Potent inhibition of microRNA in vivo without degradation
title_short Potent inhibition of microRNA in vivo without degradation
title_sort potent inhibition of microrna in vivo without degradation
topic RNA
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615630/
https://www.ncbi.nlm.nih.gov/pubmed/19015151
http://dx.doi.org/10.1093/nar/gkn904
work_keys_str_mv AT davisscott potentinhibitionofmicrornainvivowithoutdegradation
AT proppstephanie potentinhibitionofmicrornainvivowithoutdegradation
AT freiersusanm potentinhibitionofmicrornainvivowithoutdegradation
AT joneslaurae potentinhibitionofmicrornainvivowithoutdegradation
AT serramartinj potentinhibitionofmicrornainvivowithoutdegradation
AT kinbergergarth potentinhibitionofmicrornainvivowithoutdegradation
AT bhatbalkrishen potentinhibitionofmicrornainvivowithoutdegradation
AT swayzeerice potentinhibitionofmicrornainvivowithoutdegradation
AT bennettcfrank potentinhibitionofmicrornainvivowithoutdegradation
AT esauchristine potentinhibitionofmicrornainvivowithoutdegradation